Damora Therapeutics (DMRA) Retained Earnings (2019 - 2026)
Damora Therapeutics posted quarterly Retained Earnings of $754000.0 for Q1 2026, up 151.33% year-on-year from $300000.0 in Q1 2025, and down 5.99% on a QoQ basis from $802000.0 in Q4 2025.
Damora Therapeutics (DMRA) has 8 years of Retained Earnings data on file, last reported at $754000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 151.33% year-over-year to $754000.0; the trailing twelve-month figure through Mar 2026 stood at $754000.0 (up 151.33% YoY), and the FY2025 full-year result was $802000.0, up 726.8% from the prior year.
- Retained Earnings for Q1 2026 stood at $754000.0, down from $802000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $809000.0 in Q2 2025 and bottomed at -$286.6 million in Q3 2025.
- The 5-year median for Retained Earnings is -$695000.0 (2022), against an average of -$112.6 million.
- The widest annual swing landed in 2022, when Retained Earnings tumbled 228776.4%; it then surged 726.8% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$217.7 million in 2022, then jumped by 100.17% to $380000.0 in 2023, then plunged by 74.47% to $97000.0 in 2024, then soared by 726.8% to $802000.0 in 2025, then retreated by 5.99% to $754000.0 in 2026.
- The last three Retained Earnings figures came in at $754000.0 (Q1 2026), $802000.0 (Q4 2025), and -$286.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - | 754,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 754,000.00 |
| Dec 31, 2025 | 802,000.00 |
| Sep 30, 2025 | -286.60 Mn |
| Jun 30, 2025 | 809,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | -270.78 Mn |
| Jun 30, 2024 | -266.90 Mn |
| Mar 31, 2024 | 326,000.00 |
| Dec 31, 2023 | 380,000.00 |
| Sep 30, 2023 | -249.61 Mn |
| Jun 30, 2023 | -137,000.00 |
| Mar 31, 2023 | -230.73 Mn |
| Dec 31, 2022 | -217.74 Mn |
| Sep 30, 2022 | -203.70 Mn |
| Jun 30, 2022 | -189.94 Mn |
| Mar 31, 2022 | -695,000.00 |
| Dec 31, 2021 | -320,000.00 |
| Sep 30, 2021 | -89,000.00 |
| Jun 30, 2021 | -130.01 Mn |
| Mar 31, 2021 | 70,000.00 |
| Dec 31, 2020 | 674,000.00 |
| Sep 30, 2020 | -92.78 Mn |
| Dec 31, 2019 | -2.45 Mn |